VAISHALI PHARMA
Back to Balance Sheet
|
VAISHALI PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-0.18 Cr | ₹-0.14 Cr | ₹-0.16 Cr | ₹-0.15 Cr | ₹-0.12 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of VAISHALI PHARMA ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2024 | ₹-0.18 Cr |
| Mar2023 | ₹-0.14 Cr |
| Mar2022 | ₹-0.16 Cr |
| Mar2021 | ₹-0.15 Cr |
| Mar2020 | ₹-0.12 Cr |
How is Deferred Tax Assets / Liabilities of VAISHALI PHARMA Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2024 | ₹-0.18 Cr | Negative | |
| Mar2023 | ₹-0.14 Cr | Negative | |
| Mar2022 | ₹-0.16 Cr | Negative | |
| Mar2021 | ₹-0.15 Cr | Negative | |
| Mar2020 | ₹-0.12 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of VAISHALI PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VAISHALI PHARMA | ₹127.1 Cr | -3% | -13.3% | -47.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,147.0 Cr | 0.2% | 2.3% | -9.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,708.0 Cr | -1.3% | 9.1% | 16.7% | Stock Analytics | |
| CIPLA | ₹121,525.0 Cr | 0.2% | -0.6% | -3.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,147.0 Cr | 0.6% | 1% | 10.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,596.0 Cr | 0.6% | -3.5% | -4.3% | Stock Analytics | |
VAISHALI PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VAISHALI PHARMA | -3% |
-13.3% |
-47.9% |
| SENSEX | -1.4% |
1.7% |
4.8% |
You may also like the below Video Courses